The United States Biomarker Tests Market is further driven by strong pharmaceutical and biotechnology research, advanced diagnostic infrastructure, increasing clinical trial activity, and growing investment in precision medicine and targeted therapies. Rapid advances in genomic sequencing, molecular diagnostics, companion diagnostics, and multi-omics technologies are creating new opportunities...